Bionano Genomics (BNGO) Short Interest Ratio & Short Volume $3.77 +0.03 (+0.80%) Closing price 05/20/2025 04:00 PM EasternExtended Trading$3.80 +0.03 (+0.82%) As of 07:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bionano Genomics Short Interest DataBionano Genomics (BNGO) has a short interest of 486,200 shares, representing 15.73% of the float (the number of shares available for trading by the public). This marks a -18.61% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 103,507 shares to cover all short positions.Current Short Interest486,200 sharesPrevious Short Interest597,400 sharesChange Vs. Previous Month-18.61%Dollar Volume Sold Short$1.94 millionShort Interest Ratio3.5 Days to CoverLast Record DateApril 30, 2025Outstanding Shares3,364,000 sharesFloat Size3,090,000 sharesShort Percent of Float15.73%Today's Trading Volume121,736 sharesAverage Trading Volume103,507 sharesToday's Volume Vs. Average118% Short Selling Bionano Genomics? Sign up to receive the latest short interest report for Bionano Genomics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNGO Short Interest Over TimeBNGO Days to Cover Over TimeBNGO Percentage of Float Shorted Over Time Bionano Genomics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025486,200 shares $1.94 million -18.6%15.7%3.5 $3.99 4/15/2025597,400 shares $2.67 million +1.6%19.3%3.1 $4.47 3/31/2025587,800 shares $1.64 million +15.7%19.6%3.3 $2.79 3/15/2025508,200 shares $1.76 million +0.3%18.7%2.4 $3.47 2/28/2025506,700 shares $2.11 million +7.6%18.6%2.4 $4.16 2/15/2025471,100 shares $2.71 million +6.1%17.3%2.3 $5.76 1/31/2025443,900 shares $2.30 million +30.0%19.1%2.4 $5.19 1/15/2025341,500 shares $4.07 million -98.1%14.7%2.4 $11.92 12/31/202417,650,000 shares $5.09 million +11.4%12.7%2.6 $0.29 12/15/202415,840,000 shares $3.80 million +25.1%15.6%5.5 $0.24 Get the Latest News and Ratings for BNGO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202412,660,000 shares $3.29 million +4.5%12.5%4.8 $0.26 11/15/202412,110,000 shares $2.98 million +23.2%12.0%5.2 $0.25 10/31/20249,830,000 shares $2.85 million +28.2%10.3%4.9 $0.29 10/15/20247,670,000 shares $2.53 million +26.4%9.0%4.2 $0.33 9/30/20246,070,000 shares $2.76 million +45.9%8.8%3.9 $0.45 9/15/20244,160,000 shares $1.79 million +13.0%6.1%2.4 $0.43 8/31/20243,680,000 shares $1.80 million -13.0%5.4%2.1 $0.49 8/15/20244,230,000 shares $2.19 million -5.4%6.2%2.4 $0.52 7/31/20244,470,000 shares $2.87 million -7.1%6.5%2.7 $0.64 7/15/20244,810,000 shares $3.02 million -16.6%7.0%3.4 $0.63 6/30/20245,770,000 shares $3.91 million +9.9%8.4%4.1 $0.68 6/15/20245,250,000 shares $4.36 million +11.9%7.7%4 $0.83 5/31/20244,690,000 shares $4.54 million -5.8%6.9%3.6 $0.97 5/15/20244,980,000 shares $5.73 million -3.3%7.5%3.6 $1.15 4/30/20245,150,000 shares $4.55 million -3.9%7.8%3.6 $0.88 4/15/20245,360,000 shares $4.66 million +1.7%8.9%3.5 $0.87 3/31/20245,270,000 shares $5.85 million -3.7%9.8%3.2 $1.11 3/15/20245,470,000 shares $5.52 million +4.6%10.2%3.1 $1.01 2/29/20245,230,000 shares $6.54 million -7.1%9.7%2.8 $1.25 2/15/20245,630,000 shares $7.15 million +0.5%14.8%3.1 $1.27 1/31/20245,600,000 shares $6.61 million +14.5%14.7%3.1 $1.18 1/15/20244,890,000 shares $6.65 million -3.4%12.8%2.9 $1.36 12/31/20235,060,000 shares $9.56 million -1.6%13.3%3.4 $1.89 12/15/20235,140,000 shares $7.71 million -7.2%13.5%4.1 $1.50 11/30/20235,540,000 shares $8.81 million -21.8%14.5%5.6 $1.59 11/15/20237,080,000 shares $9.70 million +7.1%18.6%7.8 $1.37 10/31/20236,610,000 shares $9.12 million +15.6%19.1%7.6 $1.38 10/15/20235,720,000 shares $12.70 million +13.0%16.6%6.3 $2.22 9/30/20235,060,000 shares $15.33 million -0.8%16.9%5.8 $3.03 9/15/20235,100,000 shares $16.58 million +6.9%17.0%5 $3.25This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.Protect your savings without betraying Trump 8/31/20234,770,000 shares $18.41 million +15.2%15.7%4.3 $3.86 8/15/20234,140,000 shares $13.83 million -8.4%13.6%3.7 $3.34 7/31/20234,520,000 shares $26.56 million -89.7%N/A4.2 $5.88 7/15/202343,910,000 shares $28.45 million -8.8%N/A4.4 $0.65 6/30/202348,120,000 shares $29.35 million -19.5%N/A4.6 $0.61 6/15/202359,800,000 shares $44.22 million -4.5%N/A6.5 $0.74 5/31/202362,620,000 shares $43.33 million -2.8%N/A7.7 $0.69 5/15/202364,400,000 shares $42.67 million +3.4%N/A8.7 $0.66 4/30/202362,260,000 shares $42.83 million -1.0%N/A8.7 $0.69 4/15/202362,890,000 shares $68.55 million +8.0%N/A8.8 $1.09 3/31/202358,260,000 shares $64.67 million +6.4%N/A9.5 $1.11 3/15/202354,780,000 shares $65.74 million -5.0%N/A8.5 $1.20 2/28/202357,650,000 shares $77.25 million +17.2%N/A8.1 $1.34 2/15/202349,200,000 shares $80.20 million -5.9%N/A6.9 $1.63 1/31/202352,260,000 shares $94.59 million -1.8%N/A7.1 $1.81 1/15/202353,220,000 shares $96.33 million +2.8%N/A6.9 $1.81 12/30/202251,790,000 shares $75.61 million +6.2%N/A7 $1.46 12/15/202248,760,000 shares $94.11 million +15.6%N/A6.5 $1.93 11/30/202242,200,000 shares $84.82 million -1.3%N/A6.1 $2.01 11/15/202242,740,000 shares $120.10 million -6.6%N/A6.5 $2.81 10/31/202245,770,000 shares $107.10 million -2.1%N/A5.5 $2.34 10/15/202246,730,000 shares $95.80 million +8.4%N/A5.7 $2.05 9/30/202243,100,000 shares $78.87 million +5.2%N/A5.4 $1.83 9/15/202240,990,000 shares $96.33 million +8.4%N/A5.1 $2.35 8/31/202237,830,000 shares $93.82 million -3.4%N/A4.7 $2.48 8/15/202239,140,000 shares $140.90 million -14.2%N/A4.8 $3.60 7/31/202245,640,000 shares $84.89 million +3.3%N/A7.2 $1.86 7/15/202244,170,000 shares $68.02 million -0.3%N/A7.1 $1.54 6/30/202244,300,000 shares $61.13 million +16.4%N/A7 $1.38 6/15/202238,050,000 shares $54.41 million -1.7%N/A5.8 $1.43 5/31/202238,710,000 shares $66.97 million -3.1%N/A5.7 $1.73 5/15/202239,930,000 shares $64.69 million -11.7%N/A5.5 $1.62 4/30/202245,210,000 shares $73.69 million +2.4%N/A6.2 $1.63 4/15/202244,170,000 shares $91.43 million +13.9%N/A5.7 $2.07 3/31/202238,790,000 shares $100.08 million +1.0%N/A4.8 $2.58 3/15/202238,390,000 shares $67.18 million -0.5%N/A4.6 $1.75 2/28/202238,580,000 shares $82.56 million +0.6%N/A4.6 $2.14 2/15/202238,370,000 shares $83.65 million +1.8%N/A4.5 $2.18 1/31/202237,680,000 shares $83.65 million +0.2%N/A4.3 $2.22 1/15/202237,600,000 shares $95.88 million -7.2%N/A4.1 $2.55 12/31/202140,520,000 shares $121.15 million -2.3%N/A4.7 $2.99 12/15/202141,480,000 shares $141.86 million +3.3%N/A5 $3.42 11/30/202140,170,000 shares $157.06 million +7.1%N/A4.7 $3.91 11/15/202137,500,000 shares $187.50 million -1.4%N/A4.5 $5.00 10/29/202138,020,000 shares $193.14 million -9.5%N/A4.7 $5.08 10/15/202142,030,000 shares $216.87 million +4.2%15.1%5.5 $5.16 9/30/202140,330,000 shares $221.82 million -9.4%14.5%4.9 $5.50 9/15/202144,490,000 shares $234.91 million -2.0%16.0%4.5 $5.28 8/31/202145,390,000 shares $264.62 million No Change16.3%4.2 $5.83 8/13/202145,390,000 shares $258.27 million +8.6%16.3%3.1 $5.69This Is The Moment You Betray Trump (Or Prove Them Wrong) (Ad)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.Protect your savings without betraying Trump 7/30/202141,810,000 shares $247.93 million -6.9%15.0%2.3 $5.93 7/15/202144,920,000 shares $262.33 million -13.8%16.2%2.2 $5.84 6/30/202152,100,000 shares $381.89 million +36.2%18.8%2.2 $7.33 6/15/202138,260,000 shares $281.98 million -0.7%13.8%1.6 $7.37 5/28/202138,520,000 shares $237.67 million +5.4%13.9%1.6 $6.17 5/14/202136,550,000 shares $161.19 million +15.9%N/A1.4 $4.41 4/30/202131,530,000 shares $208.41 million +8.7%N/A1.1 $6.61 4/15/202129,020,000 shares $186.45 million +1.5%N/A0.8 $6.43 3/31/202128,580,000 shares $220.64 million +20.2%N/A0.6 $7.72 3/15/202123,780,000 shares $223.06 million +8.5%N/A0.3 $9.38 2/26/202121,920,000 shares $219.64 million +15.1%N/A0.3 $10.02 2/12/202119,050,000 shares $222.89 million -28.7%N/A0.2 $11.70 1/29/202126,700,000 shares $281.15 million +4.8%N/A0.3 $10.53 1/15/202125,470,000 shares $177.02 million +63.1%N/A0.4 $6.95 12/31/202015,620,000 shares $32.80 million +84.2%N/A0.3 $2.10 12/15/20208,480,000 shares $4.24 million +9.6%N/A1.3 $0.50 11/30/20207,740,000 shares $3.78 million +5.5%N/A1.5 $0.49 11/15/20207,340,000 shares $3.81 million +16.7%N/A1.3 $0.52 10/30/20206,290,000 shares $3.24 million +7.9%N/A1 $0.52 10/15/20205,830,000 shares $3.44 million +0.5%N/A0.6 $0.59 9/30/20205,800,000 shares $3.77 million +6.8%N/A0.3 $0.65 9/15/20205,430,000 shares $3.25 million +7.5%N/A0.2 $0.60 8/31/20205,050,000 shares $3.07 million +16.9%N/A0.2 $0.61 8/14/20204,320,000 shares $3.04 million -43.2%N/A0.2 $0.70 7/31/20207,600,000 shares $6.00 million +49.9%N/A0.3 $0.79 7/15/20205,070,000 shares $2.56 million +28.4%N/A0.2 $0.50 6/30/20203,950,000 shares $2.01 million -16.7%N/A0.4 $0.51 6/15/20204,740,000 shares $2.47 million +14.2%N/A0.6 $0.52 5/29/20204,150,000 shares $1.86 million +14.0%N/A0.6 $0.45 BNGO Short Interest - Frequently Asked Questions What is Bionano Genomics' current short interest? Short interest is the volume of Bionano Genomics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 486,200 shares of BNGO short. 15.73% of Bionano Genomics' shares are currently sold short. Learn More on Bionano Genomics' current short interest. What is a good short interest ratio for Bionano Genomics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNGO shares currently have a short interest ratio of 4.0. Learn More on Bionano Genomics's short interest ratio. Which institutional investors are shorting Bionano Genomics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bionano Genomics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Bionano Genomics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.73% of Bionano Genomics' floating shares are currently sold short. Is Bionano Genomics' short interest increasing or decreasing? Bionano Genomics saw a drop in short interest in April. As of April 30th, there was short interest totaling 486,200 shares, a drop of 18.6% from the previous total of 597,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bionano Genomics' float size? Bionano Genomics currently has issued a total of 3,364,000 shares. Some of Bionano Genomics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bionano Genomics currently has a public float of 3,090,000 shares. How does Bionano Genomics' short interest compare to its competitors? 15.73% of Bionano Genomics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Bionano Genomics: Optex Systems Holdings, Inc (0.24%), ClearSign Technologies Co. (0.41%), MultiSensor AI Holdings, Inc. (1.77%), Data I/O Co. (0.11%), Precipio, Inc. (1.89%), Astrotech Co. (0.09%), Accelerate Diagnostics, Inc. (1.94%), Trane Technologies plc (1.92%), Keysight Technologies, Inc. (1.41%), Fortive Co. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Bionano Genomics stock? Short selling BNGO is an investing strategy that aims to generate trading profit from Bionano Genomics as its price is falling. BNGO shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bionano Genomics? A short squeeze for Bionano Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNGO, which in turn drives the price of the stock up even further. How often is Bionano Genomics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNGO, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies OPXS Short Interest Data CLIR Short Interest Data MSAI Short Interest Data DAIO Short Interest Data PRPO Short Interest Data ASTC Short Interest Data AXDX Short Interest Data PRENW Short Interest Data QSIAW Short Interest Data TT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNGO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNGO Stock Free BNGO Stock Alerts